LC-MS/MS determination of GTS-201, a dipeptide mimetic of the brain-derived neurotrophic factor, and neurotransmitter metabolites with application to a pharmacokinetic study in ratsJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12023-01-014PRE
Antidepressant-like Effects of BDNF and NGF Individual Loop Dipeptide Mimetics Depend on the Signal Transmission Patterns Associated with TrkPHARMACEUTICALSIF4.82022-02-246OAAI
Nootropic effects of the brain neurotrophic factor dipeptide mimetic GSB-214 in models of Alzheimer's diseaseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Novel pyrrolo[1,2-a]pyrazines TSPO ligands ameliorate SH-SY5Y cells survival upon lipopolysaccharide-induced cell damageEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Dimeric mimetic of BDNF loop 4 promotes survival of serum-deprived cell through TrkB-dependent apoptosis suppressionSCIENTIFIC REPORTSIF3.92021-04-0812OAAI
PI3K/Akt pathway involvement in behavioral effects of low-molecular-weight BDNF and NGF mimetics on diabetes modelEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-03-010PREAI
Low-molecular weight NGF mimetic attenuates the manifestation of diabetic neuropathy (experimental study)EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-03-010PREAI
The New Dipeptide TSPO Ligands: Design, Synthesis and Structure-Anxiolytic Activity Relationship †MOLECULESIF4.62020-11-0411OAAI
Endogenous neuropeptide cycloprolylglycine involves in regulation of HIF-1-dependent pathwayEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-010PREAI
New dipeptide mimetic of 2-nd loop of BDNF attenuates individual behavioral signs of opioid dependence in ratsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-010PREAI
Survival of serum-deprived cells is mediated by antiapoptotic properties of BDNF small dipeptide mimeticEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-010PREAI
Low-molecular mimetics of nerve growth factor and brain-derived neurotrophic factor: Design and pharmacological propertiesMEDICINAL RESEARCH REVIEWSIF11.62020-08-1834PREAI
Antidepressant-like activity of cyclo-l-prolylglycine and its possible mechanismEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-012PREAI
New types of activity of the BDNF dipeptide mimetic: An psychostimulant, anti-opioid and anti-craving effects in opiate dependent rodentsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-011PREAI
BAD activation is involved in survival-promoting effect of NGF and BDNF dipeptide mimeticsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-010PREAI
A novel dimeric dipeptide mimetics of the BDNF loop 1, 2 and 4 activate the phospholipase cγ signaling pathwayEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-010PREAI
Experimental study of endogenous dipeptide Cyclo-L-prolylglycine in aspects of opioid addiction and analgesia in rodentsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-014PREAI
Low-molecular mimetic of BDNF loop 2 protected neurons against oxidative stress via the TrkB and MAPK/Erk activationEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI
The delayed protective effect of GK-2, a dipeptide mimetic of Nerve Growth Factor, in a model of rat traumatic brain injuryBRAIN RESEARCH BULLETINIF3.72018-06-0110PREAI
Effects of new low-molecular mimetic of NGF loop 3 on the activation of TrkA-receptor, PI3K/AKT and MAPK/ERK signaling pathwaysEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72016-10-011PREAI